Operations & Management

The proposed 2019 Outpatient Prospective Payment System rules have been published in the Federal Register and will take effect on Jan. 1, 2019.

Medication payment rules are changing. Here's an review of important terms and an update on proposed and enacted rule changes.

Healthcare costs continues to rise, but practitioners can help by meeting the reimbursement requirements for Part B drugs in outpatient settings.

Billing for drug waste sounds simple, but can be confusing. These reminders can help healthcare facilities identify what is billable.

For 2018, the proposed changes to the OPPS rules have been published in the Federal Register, the comment period has ended, and the final rules will be decided before the year’s end.

With the cost of medications in hospitals, outpatient areas, physician offices and at home surging at an unprecedented rate, emphasis is on drug pricing reform and cost management.

The 340B program is under close scrutiny, with stakeholders reviewing its policies, procedures and discounts, among other issues.

The philosophical shift in healthcare payment reform is moving away from fee-for-service to a variety of models, including bundled payments that pay for value.

Recently published proposed changes to the outpatient prospective payment system affect drugs and biologicals. Here are suggestions for how to implement best practices.

New proposals, models and rules from the Centers for Medicare and Medicaid Services, the U.S. Food and Drug Administration and the Department of Health and Human Services will affect payments this spring.